Immunogenicity, Reactogenicity, and Safety of AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein-based Candidate Vaccine (RSVPreF3 OA) When Coadministered With a Seasonal Quadrivalent Influenza Vaccine in Older Adults: Results of a Phase 3